There are also higher costs and price pressure for some drugs. The Dax group announced on Tuesday in Leverkusen that sales of 51 to 52 billion euros are expected in 2023, adjusted for the effects of exchange rate changes and therefore at average monthly exchange rates for 2022. On this basis, the adjusted operating result (Ebitda) should reach between 12.5 and 13 billion euros.
Bayer increased its sales by a good 15 percent to €50.7 billion in 2022 and adjusted its operating profit by more than one-fifth to €13.5 billion. Both values are at market expectations. As a result, earnings quadrupled to 4.15 billion euros. As experts expected, the dividend will now rise 40 cents to 2.40 euros per share. (SDA)
Source :Blick
I’m Tim David and I work as an author for 24 Instant News, covering the Market section. With a Bachelor’s Degree in Journalism, my mission is to provide accurate, timely and insightful news coverage that helps our readers stay informed about the latest trends in the market. My writing style is focused on making complex economic topics easy to understand for everyone.
